Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day
Clinical trial NCT03234465 · TERMINATED
Trial details
- NCT number
- NCT03234465
- Sponsor
- Oragenics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-18
- Primary completion
- 2020-03-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.